Target intelligence / Profile preview

Cytochrome P450 3A11 (Cyp3a11)

Target
Cyp3a11
Molecular classification
Enzyme, Monooxygenase, Cytochrome P450 (CYP) family
01

Overview

Cytochrome P450 3A11 is a heme-thiolate monooxygenase enzyme of the cytochrome P450 superfamily and the primary hepatic CYP3A isoform in mice, functionally homologous to human CYP3A4. It catalyzes the oxidative metabolism (hydroxylation) of a broad range of endogenous compounds (such as steroids, bile acids, cholesterol, and vitamin D) and xenobiotics, including many clinically important drugs. Its expression is transcriptionally regulated by nuclear receptors like PXR and is modulated by dietary, hormonal, circadian, and epigenetic factors. Cyp3a11 plays an essential role in drug detoxification, and variations in its activity or expression significantly affect drug efficacy and toxicity in preclinical mouse models. It is widely used in pharmacological studies for predicting drug-drug interactions and metabolic profiles in animal models before translation to human studies.

Other names
Cytochrome P450, family 3, subfamily a, polypeptide 11CYP3A11
02

Mechanism of action

Monooxygenase activity—mediates oxidation of drugs, steroids, and lipids (drug detoxification); Substrate hydroxylation, increasing hydrophilicity for hepatic clearance; Regulation by PXR (Pregnane X Receptor)

03

Biological functions

Drug metabolismOxidation-reduction processLipid and steroid metabolismDetoxification of endogenous and exogenous compounds
04

Disease associations

Drug response/Drug-drug interactionsHormone regulation disordersHepatic (liver) diseaseOther
05

Safety considerations

Variability in expression leads to altered drug metabolism, resulting in toxicity or therapeutic failure, especially in circadian disruption or with inducers/inhibitorsMouse-specific enzyme—does not always directly translate to human drug metabolism
06

Interacting drugs

Rifampin (induces expression via PXR activation)

3 more in the full profile.

07

Biomarkers

Expression levels in liver (as a marker for drug-metabolizing capacity)Circadian rhythm markers, as Cyp3a11 exhibits circadian expression

Beyond the preview

Go deeper on Cytochrome P450 3A11 (Cyp3a11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 3A11 (Cyp3a11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call